HUP0302940A2 - Karbamátvegyületek alkalmazása neuropátiás fájdalom és cluster és migrén fejfájással kapcsolatos fájdalom megelőzésére - Google Patents

Karbamátvegyületek alkalmazása neuropátiás fájdalom és cluster és migrén fejfájással kapcsolatos fájdalom megelőzésére

Info

Publication number
HUP0302940A2
HUP0302940A2 HU0302940A HUP0302940A HUP0302940A2 HU P0302940 A2 HUP0302940 A2 HU P0302940A2 HU 0302940 A HU0302940 A HU 0302940A HU P0302940 A HUP0302940 A HU P0302940A HU P0302940 A2 HUP0302940 A2 HU P0302940A2
Authority
HU
Hungary
Prior art keywords
pain
cluster
carbamate compounds
group
preventing
Prior art date
Application number
HU0302940A
Other languages
English (en)
Inventor
Ellen E. Codd
Carlos R. Plata-Salaman
Katherine E. Rogers
Richard P. Shank
Boyu Zhao
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0302940(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of HUP0302940A2 publication Critical patent/HUP0302940A2/hu
Publication of HUP0302940A3 publication Critical patent/HUP0302940A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány tárgya karbamátvegyületek alkalmazása neuropátiás fájdalomés cluster és migrén fejfájással kapcsolatos fájdalom kezelésére vagymegelőzésére. Az (I) általános képletben: a fenilcsoport Xjelentésében 1-5 halogénatommal, mégpedig egymástól függetlenülfluor-, klór-, bróm- vagy jódatommal van szubsztituálva; R1 és R2egymástól függetlenül hidrogénatom vagy 1-4 szénatomos alkilcsoport,ahol az 1-4 szénatomos alkilcsoport adott esetben fenilcsoporttalszubsztituált, ahol a fenilcsoport adott esetben egymástól függetlenülhalogénatommal, 1-4 szénatomos alkil- vagy 1-4 szénatomosalkoxicsoporttal, amino-, nitro- vagy cianocsoporttal vanszubsztituálva. Ó
HU0302940A 2000-07-21 2001-07-16 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain HUP0302940A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21
PCT/US2001/022322 WO2002007822A2 (en) 2000-07-21 2001-07-16 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (2)

Publication Number Publication Date
HUP0302940A2 true HUP0302940A2 (hu) 2003-12-29
HUP0302940A3 HUP0302940A3 (en) 2012-02-28

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302940A HUP0302940A3 (en) 2000-07-21 2001-07-16 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Country Status (28)

Country Link
US (4) US20020107283A1 (hu)
EP (1) EP1305082B1 (hu)
JP (1) JP5271473B2 (hu)
KR (1) KR100792814B1 (hu)
CN (1) CN1250213C (hu)
AT (1) ATE267629T1 (hu)
AU (2) AU2001273493B2 (hu)
BG (1) BG107529A (hu)
BR (1) BR0112713A (hu)
CA (1) CA2416819C (hu)
CZ (1) CZ2003445A3 (hu)
DE (1) DE60103546T2 (hu)
DK (1) DK1305082T3 (hu)
EA (1) EA005648B1 (hu)
ES (1) ES2221651T3 (hu)
HU (1) HUP0302940A3 (hu)
IL (2) IL154052A0 (hu)
MX (1) MXPA03000619A (hu)
MY (1) MY127317A (hu)
NO (1) NO330055B1 (hu)
NZ (1) NZ523851A (hu)
PL (1) PL365701A1 (hu)
PT (1) PT1305082E (hu)
SK (1) SK1962003A3 (hu)
TR (1) TR200401511T4 (hu)
UA (1) UA74195C2 (hu)
WO (1) WO2002007822A2 (hu)
ZA (1) ZA200301403B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067922A1 (en) 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in the treatment of pain
CA2454049A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
CN1592617A (zh) * 2001-07-16 2005-03-09 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
EP1850841A1 (en) * 2005-01-20 2007-11-07 Janssen Pharmaceutica N.V. Methods for qt interval control
KR101541383B1 (ko) 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2008063284A2 (en) * 2006-10-10 2008-05-29 Janssen Pharmaceutica Nv Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
KR20010013435A (ko) * 1997-06-05 2001-02-26 고든 라이트 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
NZ527991A (en) * 2001-02-27 2005-04-29 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating psychotic disorders
PL364638A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
NZ551954A (en) * 2001-02-27 2008-07-31 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating movement disorders

Also Published As

Publication number Publication date
DE60103546T2 (de) 2005-06-09
CN1458853A (zh) 2003-11-26
BG107529A (bg) 2003-09-30
ATE267629T1 (de) 2004-06-15
PL365701A1 (en) 2005-01-10
UA74195C2 (uk) 2005-11-15
SK1962003A3 (en) 2004-08-03
EP1305082A2 (en) 2003-05-02
IL154052A (en) 2008-07-08
CA2416819C (en) 2011-03-22
JP5271473B2 (ja) 2013-08-21
CA2416819A1 (en) 2002-01-31
NZ523851A (en) 2004-09-24
PT1305082E (pt) 2004-09-30
MY127317A (en) 2006-11-30
KR100792814B1 (ko) 2008-01-14
US20020107283A1 (en) 2002-08-08
EP1305082B1 (en) 2004-05-26
EA200300042A1 (ru) 2003-06-26
EA005648B1 (ru) 2005-04-28
NO330055B1 (no) 2011-02-14
HUP0302940A3 (en) 2012-02-28
TR200401511T4 (tr) 2004-08-23
ES2221651T3 (es) 2005-01-01
MXPA03000619A (es) 2004-07-30
IL154052A0 (en) 2003-07-31
NO20030299D0 (no) 2003-01-20
WO2002007822A3 (en) 2002-05-30
ZA200301403B (en) 2004-06-15
NO20030299L (no) 2003-03-12
US20060183795A1 (en) 2006-08-17
AU2001273493B2 (en) 2005-08-11
DK1305082T3 (da) 2004-09-13
KR20030022300A (ko) 2003-03-15
CZ2003445A3 (cs) 2004-08-18
BR0112713A (pt) 2003-07-22
US20090281179A1 (en) 2009-11-12
DE60103546D1 (de) 2004-07-01
WO2002007822A2 (en) 2002-01-31
JP2004504362A (ja) 2004-02-12
AU7349301A (en) 2002-02-05
CN1250213C (zh) 2006-04-12
US20040266866A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
HUP0302940A2 (hu) Karbamátvegyületek alkalmazása neuropátiás fájdalom és cluster és migrén fejfájással kapcsolatos fájdalom megelőzésére
RS67603A (en) Carbamate compounds for use in the treatment of pain
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
DE60210960D1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
HUP0401367A2 (hu) Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére
HUP0401110A2 (hu) Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees